Tikki Pang

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Impact of pharmacogenomics on neglected diseases of the developing world
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Am J Pharmacogenomics 3:393-8. 2003
  2. ncbi Diagnostic tests for infectious diseases in the developing world: two sides of the coin
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Ave Appia, 1211, Geneva 27, Switzerland
    Trans R Soc Trop Med Hyg 101:856-7. 2007
  3. ncbi Vaccines for the prevention of neglected diseases--dengue fever
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Avenue Appia, 1211 Geneva 27, Switzerland
    Curr Opin Biotechnol 14:332-6. 2003
  4. pmc Globalization and risks to health
    Tikki Pang
    Department of Research Policy and Cooperation at the World Health Organization, Geneva, Switzerland
    EMBO Rep 5:S11-6. 2004
  5. ncbi Complementary strategies for efficient use of knowledge for better health
    Tikki Pang
    Research Policy and Cooperation, WHO, 1211, Geneva, Switzerland
    Lancet 361:716. 2003
  6. ncbi Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS)
    Tikki Pang
    Department of Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Immunol Cell Biol 85:43-5. 2007
  7. pmc The impact of genomics on global health
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Am J Public Health 92:1077-9. 2002
  8. ncbi A 15th grand challenge for global public health
    Tikki Pang
    Research Policy and Cooperation, Evidence and Information for Policy, WHO, CH 1211 Geneva, Switzerland
    Lancet 367:284-6. 2006
  9. pmc Knowledge for better health: a conceptual framework and foundation for health research systems
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 81:815-20. 2003
  10. ncbi Overcoming health-systems constraints to achieve the Millennium Development Goals
    Phyllida Travis
    Department of Health System Policies, WHO, Geneva, Switzerland
    Lancet 364:900-6. 2004

Detail Information

Publications39

  1. ncbi Impact of pharmacogenomics on neglected diseases of the developing world
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Am J Pharmacogenomics 3:393-8. 2003
    ..Simultaneously, more equitable and active participation from developing country researchers themselves is critical in overcoming these challenges...
  2. ncbi Diagnostic tests for infectious diseases in the developing world: two sides of the coin
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Ave Appia, 1211, Geneva 27, Switzerland
    Trans R Soc Trop Med Hyg 101:856-7. 2007
    ....
  3. ncbi Vaccines for the prevention of neglected diseases--dengue fever
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Avenue Appia, 1211 Geneva 27, Switzerland
    Curr Opin Biotechnol 14:332-6. 2003
    ..Vector control, community education and public health measures must be pursued in parallel with vaccine development...
  4. pmc Globalization and risks to health
    Tikki Pang
    Department of Research Policy and Cooperation at the World Health Organization, Geneva, Switzerland
    EMBO Rep 5:S11-6. 2004
  5. ncbi Complementary strategies for efficient use of knowledge for better health
    Tikki Pang
    Research Policy and Cooperation, WHO, 1211, Geneva, Switzerland
    Lancet 361:716. 2003
  6. ncbi Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS)
    Tikki Pang
    Department of Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Immunol Cell Biol 85:43-5. 2007
    ....
  7. pmc The impact of genomics on global health
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Am J Public Health 92:1077-9. 2002
    ..Creative and equitable international mechanisms and goodwill are needed to turn high hopes into reality and allow the use of genomics to reduce health inequities between rich and poor nations...
  8. ncbi A 15th grand challenge for global public health
    Tikki Pang
    Research Policy and Cooperation, Evidence and Information for Policy, WHO, CH 1211 Geneva, Switzerland
    Lancet 367:284-6. 2006
  9. pmc Knowledge for better health: a conceptual framework and foundation for health research systems
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 81:815-20. 2003
    ..The framework, as it is applied in consultation with countries, will provide countries and donor agencies with relevant inputs to policies and strategies for strengthening HRSs and using knowledge for better health...
  10. ncbi Overcoming health-systems constraints to achieve the Millennium Development Goals
    Phyllida Travis
    Department of Health System Policies, WHO, Geneva, Switzerland
    Lancet 364:900-6. 2004
    ..The forthcoming Ministerial Summit on Health Research seeks to help define a learning agenda for health systems, so that by 2015, substantial progress will have been made to reducing the system constraints to achieving the MDGs...
  11. doi From Mexico to Mali: a new course for global health
    Carel IJsselmuiden
    Council on Health Research for Development, Geneva, Switzerland
    Lancet 371:91-3. 2008
  12. ncbi Clinical trial registration: transparency is the watchword
    Ida Sim
    Department of Research Policy and Cooperation, World Health Organization, 1211 Geneva 27, Switzerland
    Lancet 367:1631-3. 2006
  13. ncbi WHO facilitates international collaboration in setting standards for clinical trial registration
    A Metin Gulmezoglu
    UNDP UNFPA WHO World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Lancet 365:1829-31. 2005
  14. doi En route to international clinical trial transparency
    Davina Ghersi
    International Clinical Trials Registry Platform ICTRP, Department of Research Policy and Cooperation, WHO, CH 1211 Geneva 27, Switzerland
    Lancet 372:1531-2. 2008
  15. ncbi Commentary on 'reflections and recommendations on research ethics in developing countries' by S.R. Benatar
    Tikki Pang
    Research Policy and Cooperation, World Health Organization, Geneva, Switzerland
    Soc Sci Med 54:1145-6; discussion 1147-8. 2002
  16. doi Evaluating the global 'Evidence Footprint': how can evidence better serve the needs of global public health?
    Tikki Pang
    Director of Department of Research Policy and Cooperation, World Health Organization, Switzerland
    J Evid Based Med 2:44-6. 2009
    ....
  17. ncbi Health information for all by 2015?
    Christopher Bailey
    World Health Organization, CH 1211 Geneva 27, Switzerland
    Lancet 364:223-4. 2004
  18. ncbi Leading by example: a culture change at WHO
    Suzanne Hill
    Medicines Policy and Standards, World Health Organization, Geneva, Switzerland
    Lancet 369:1842-4. 2007
  19. doi From Mexico to Mali: four years in the history of clinical trial registration
    Davina Ghersi
    International Clinical Trials Registry Platform, Research Policy and Cooperation Department, World Health Organization, Geneva, Switzerland
    J Evid Based Med 2:1-7. 2009
    ..However, despite these advances and incentives, trial registration in many countries remains far from comprehensive and stronger enforcement mechanisms may be needed in those countries...
  20. doi The WHO must reform for its own health
    Tikki Pang
    World Health Organization, Geneva, Switzerland
    Nat Med 18:646. 2012
    ..To ensure its leading role, it must rethink its internal governance and revamp its financing mechanisms...
  21. ncbi Registering clinical trials: an essential role for WHO
    Timothy Evans
    Evidence and Information for Policy, World Health Organization, Geneva, CH 1211, Switzerland
    Lancet 363:1413-4. 2004
  22. pmc Vision for a global registry of anticipated public health studies
    Bernard C K Choi
    Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, Government of Canada, Ottawa, Ontario, Canada Bernard_
    Am J Public Health 97:S82-7. 2007
    ..This prospective, comprehensive system for tracking research in public health could help enhance collaboration and improve efficiency. Practical problems must be discussed before such a vision can be further developed...
  23. pmc Can scientists and policy makers work together?
    Bernard C K Choi
    Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, Government of Canada
    J Epidemiol Community Health 59:632-7. 2005
    ....
  24. ncbi Filling the gap between knowing and doing
    Tikki Pang
    Nature 426:383. 2003
  25. pmc Genomics and global health
    Tikki Pang
    BMJ 324:1051-2. 2002
  26. ncbi Equal partnership to ensure that developing countries benefit from genomics
    Tikki Pang
    Nat Genet 33:18. 2003
  27. pmc Health research systems: a framework for the future
    Ritu Sadana
    Bull World Health Organ 81:159. 2003
  28. pmc From Bangkok to Mexico: towards a framework for turning knowledge into action to improve health systems
    Tikki Pang
    Bull World Health Organ 82:720-1. 2004
  29. ncbi Health research: find the charcoal first
    Tikki Pang
    Lancet 364:2091. 2004
  30. pmc A global player for public health. An interview with Tikki Pang, Director of Research Policy and Cooperation at the World Health Organization [interviewed by Holger Breithaupt and Caroline Hadley]
    Tikki Pang
    EMBO Rep 4:737-40. 2003
  31. pmc Setting global health research priorities: ethics should also guide global health research
    Tikki Pang
    BMJ 326:1399. 2003
  32. pmc Evidence to action in the developing world: what evidence is needed?
    Tikki Pang
    Bull World Health Organ 85:247. 2007
  33. ncbi EVIPNet: translating the spirit of Mexico
    Maimunah Hamid
    Institute for Health Systems Research, Ministry of Health, Kuala Lumpur, Malaysia
    Lancet 366:1758-60. 2005
  34. ncbi Implementation of good clinical practice guidelines in vaccine trials in developing countries
    Camilo J Acosta
    International Vaccine Institute, Seoul, Republic of Korea
    Vaccine 25:2852-7. 2007
    ..The ICH GCP principles are discussed below within the framework of this recent typhoid fever vaccine study experience...
  35. ncbi The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia
    Camilo J Acosta
    International Vaccine Institute, Seoul, Republic of Korea
    J Health Popul Nutr 22:240-5. 2004
    ..Epidemiological studies contribute to all stages of development of vaccine evaluation and introduction...
  36. ncbi Assessing clinical trial results
    An Wen Chan
    Science 312:365-6; author reply 365-6. 2006
  37. pmc The Mexico Summit on Health Research 2004: Mexico agenda was informed by wide consultation
    Tikki Pang
    BMJ 330:421. 2005
  38. ncbi A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design
    Camilo J Acosta
    International Vaccine Institute, Seoul, South Korea
    Trop Med Int Health 10:1219-28. 2005
    ..Preliminary results are presented that determined the final planning of the trial before immunization. Important methodological and practical issues regarding vaccine cluster randomized designs are illustrated...
  39. pmc Brain drain and health professionals
    Tikki Pang
    BMJ 324:499-500. 2002